Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs Nova MD

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Nova MD a 73. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

Nova MD

#178 · Grade C+ · Watch List

Est. first month

From $125/mo (3-month plan, compounded)

Save ~91% vs brand-name
Get this deal Full Nova MD review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 73 an est. $99/mo first month, with no teaser step-up baked in. Nova MD isn't out of it: Shoppers who want lowest 3-month compounded pricing with an explicit microdose program.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDNova MD
Value Score89 (A)73 (C+)
Est. first month$99/moFrom $125/mo (3-month plan, compounded)
Save vs brand-name~93%~91%
Semaglutide$99/moFrom $125/mo (3-month plan, compounded)
Tirzepatide$139/moFrom $199/mo (3-month plan, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
87
bmiMD: 95. Nova MD: 87.
84
No Teaser-Rate Bait
62
bmiMD: 84. Nova MD: 62.
98
Nationwide Availability
45
bmiMD: 98. Nova MD: 45.
94
Both Molecules
92
bmiMD: 94. Nova MD: 92.
82
Easy Cancellation
58
bmiMD: 82. Nova MD: 58.
70
Reputation
68
bmiMD: 70. Nova MD: 68.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

Nova MD

Nova MD is a telehealth platform offering compounded semaglutide and tirzepatide on 1-month and 3-month plans, with an uncommon explicit microdose program for both molecules.

Why it's a deal

  • On-page pricing published for all four SKUs (semaglutide and tirzepatide, 1- and 3-month)
  • $125/mo semaglutide and $199/mo tirzepatide 3-month plans rank among the cheapest in the market
  • $50 off first tirzepatide order shown publicly
  • Explicit microdose / low-dose program for both semaglutide and tirzepatide
  • Broader menu (sermorelin, NAD+, glutathione, enclomiphene) for longevity alongside GLP-1

The fine print

  • Legal entity name and state of incorporation not disclosed
  • Compounding pharmacy not named — only 'accredited facilities'
  • LegitScript certification not confirmed (only 'Licensed US Providers' claims)
  • Per-state availability not listed
  • Compounded only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic
Get the bmiMD deal Get the Nova MD deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Nova MD.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.